[ACL] QoQ Quarter Result on 31-Dec-2022 [#Q2]

Stock
[ACL] Australian Clinical Labs Limited
Announcement Date
29-Dec-2022
Financial Year
2023
Quarter
31-Dec-2022 [#Q2]
Profit Trend
QoQ- 99.99%
YoY- -80.48%
Quarter Report
ACL's Result
ACL's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 168,634 336,760 168,380 360,312 180,156 457,603 228,802 -18.39%
PBT 3,903 15,554 7,777 32,756 16,378 69,956 34,978 -76.79%
Tax 1,366 4,994 2,497 7,274 3,637 21,842 10,921 -74.95%
NP 2,476 10,480 5,240 25,421 12,711 48,030 24,015 -77.98%
Tax Rate -34.99% -32.11% -32.11% -22.21% -22.21% -31.22% -31.22% -
Total Cost 166,158 326,280 163,140 334,891 167,446 409,573 204,787 -12.99%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin 1.47 3.11 3.11 7.06 7.06 10.50 10.50 -73.00%
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS 0.01 0.05 0.03 0.13 0.06 0.24 0.12 -80.89%
EPS Diluted 0.01 0.05 0.03 0.13 0.06 0.24 0.12 -80.89%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.